Innovotech (IOTCF) reported a third-quarter 2026 net loss of C$390,335, narrowing 40% from the second quarter as costs declined. Revenue held steady at C$661,762, and loss per share was C$0.01. Gross margin rose to 29.8% from 8.6% in the second quarter. Total costs before grants and tax credits fell 22% sequentially to C$1.11 million; general and administrative expenses declined 24% to C$413,276.
Regulated testing services revenue reached C$363,112, up 9% year over year and 13% sequentially. Working capital was C$712,523 at September 30, and the current ratio improved to 2.28 from 2.07 at June 30. On October 29, Innovotech accepted an ATB Financial commitment for a C$500,000 revolving operating facility and a C$100,000 corporate credit card facility. The company expects its reduced cost base to be more fully reflected in the fourth quarter and remains focused on returning to profitability.
Innovotech (IOTCF) signed an exclusive Canadian distribution agreement with Healthmark Services for its InnovoTEST hazardous drug wipe testing kits. The agreement is effective immediately for an initial three-year term. Healthmark will offer the kits to hospital, community and long-term care pharmacy customers across Canada.
The companies will jointly support pharmacies in setting up and maintaining surface monitoring programs. Samples are analyzed at accredited Canadian facilities. Innovotech sees the agreement as a step toward recurring testing revenue and an opportunity to expand sterility testing and environmental monitoring services with pharmacy compounding customers.
Innovotech (IOTCF) has established a banking partnership with ATB Financial, securing $600,000 in credit facilities to support growth.
The arrangement includes a $500,000 revolving operating line and a $100,000 corporate credit card facility. The non-dilutive working capital will support the commercial rollout of InnovoTEST Hazardous Drug Wipe Testing Kits and expansion of contract research and laboratory testing services. Innovotech will consolidate day-to-day banking with ATB and close legacy accounts and smaller facilities. The company expects this consolidation to reduce administrative effort and banking costs and provide a clearer view of its cash position.